Evidence map›Paper›PMID 36672826›Full record

ArticleGenes2022

Ozone Disinfection for Elimination of Bacteria and Degradation of SARS-CoV2 RNA for Medical Environments.

Craig Westover, Savlatjon Rahmatulloev, David Danko, Evan E Afshin, Niamh B O'Hara, Rachid Ounit, Daniela Bezdan, Christopher E Mason

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Ozone application in different industries: A review of recent developments.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Craig WestoverDepartment of Physiology and Biophysics, Weill Cornell Medical College, New York, NY 10065, USA.
Savlatjon RahmatulloevDepartment of Physiology and Biophysics, Weill Cornell Medical College, New York, NY 10065, USA.ORCID 0000-0001-9900-958X
David DankoJacobs Technion-Cornell Institute, Cornell Tech, New York, NY 10044, USA.
Evan E AfshinDepartment of Physiology and Biophysics, Weill Cornell Medical College, New York, NY 10065, USA.
Niamh B O'HaraJacobs Technion-Cornell Institute, Cornell Tech, New York, NY 10044, USA.
Rachid OunitDepartment of Computer Science & Engineering, University of California, Riverside, CA 92521, USA.
Daniela BezdanInstitute of Medical Genetics and Applied Genomics, University of Tübingen, 72074 Tübingen, Germany.
Christopher E MasonDepartment of Physiology and Biophysics, Weill Cornell Medical College, New York, NY 10065, USA.ORCID 0000-0002-1850-1642
Cornell University · USBernstein Center for Computational Neuroscience Tübingen · DEUniversity of California, Riverside · US

Funding

Epigenome Interactions in Complex Neurogenetic DisordersR01NS076465 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI MASON, CHRISTOPHER EDWARD, ROSS, MARGARET ELIZABETH · 2011 to 2015
$5.8M
Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycleR01AI125416 · NIAID · DUKE UNIVERSITY · PI Stacy Michelle Horner · 2016 to 2026
$5.5M
The Spatiotemporal Landscape of the Human Brain EpitranscriptomeR01MH117406 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI MASON, CHRISTOPHER EDWARD · 2018 to 2022
$3.3M
Study of Neural Tube Defects Etiology: Genome and ExposomeR01ES021006 · NIEHS · UNIVERSITY OF TEXAS AT AUSTIN · PI FINNELL, RICHARD H., MASON, CHRISTOPHER EDWARD · 2012 to 2014
$1.0M
Community Research Education and Engagement for Data Science (CREEDS)R25EB020393 · NIBIB · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CLAUDIO, LUZ, KOVATCH, PATRICIA · 2015 to 2017
$578k
Mapping the RNA modification N6-methyladenosine during Zika virus infectionR21AI129851 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI HORNER, STACY MICHELLE, MASON, CHRISTOPHER EDWARD · 2017 to 2018
$469k
NIAID NIH HHS R01 AI125416NIAID NIH HHS R21 AI129851NIBIB NIH HHS R25 EB020393NIEHS NIH HHS R01 ES021006NIMH NIH HHS R01 MH117406NINDS NIH HHS R01 NS076465
6 · The paper itself

Abstract

Pathogenic bacteria and viruses in medical environments can lead to treatment complications and hospital-acquired infections. Current disinfection protocols do not address hard-to-access areas or may be beyond line-of-sight treatment, such as with ultraviolet radiation. The COVID-19 pandemic further underscores the demand for reliable and effective disinfection methods to sterilize a wide array of surfaces and to keep up with the supply of personal protective equipment (PPE). We tested the efficacy of Sani Sport ozone devices to treat hospital equipment and surfaces for killing

Indexed as

COVID-19Cross InfectionOzoneBacteriaDisinfectionEscherichia coliHumansPandemicsRNA, ViralSARS-CoV-2Ultraviolet RaysOzoneRNA, ViralCFUdisinfectionhospital-acquired infectionsmicrobiomeozoneRNA degradationSARS-CoV-2

Identifiers

PMID36672826
PMCPMC9858956
OpenAlexW4313413415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.